![](/img/cover-not-exists.png)
A phase I study with S-1, an oral 5-FU formulation, in patients with solid tumors
Van Groeningen, C.J., Schomagel, J.H., Peters, G.J., Noordhuis, P., Van Kuilenburg, A.B.P., Shirasaka, T., Shimamura, Y., de Vries, M.J., Hanauske, A.-R.Volume:
33
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(97)86014-5
Date:
September, 1997
File:
PDF, 266 KB
english, 1997